Financial statements Wörwag Pharma Operations
Cash inflows of WÖRWAG PHARMA OPERATIONS
|
Year
|
2021
|
2022
|
2023
|
|---|---|---|---|
| Net cash from operating expenses | -15 379 635,00 | -15 497 894,38 | 4 788 487,98 |
| Net cash flow from investing activities | -6 093 057,00 | -28 535 989,40 | -29 078 750,35 |
| Net cash flow from financial activities | 24 968 335,00 | 43 522 641,01 | 25 557 158,10 |
| Total net cash flow | 3 495 643,00 | -511 242,77 | 1 266 895,73 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.